201 related articles for article (PubMed ID: 1576056)
21. Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease.
Stone DM; Frattarelli DA; Karthikeyan S; Johnson YR; Chintala K
Pediatr Cardiol; 2006; 27(3):360-3. PubMed ID: 16565906
[TBL] [Abstract][Full Text] [Related]
22. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
Katzenschlager R; Weiss K; Rogatti W; Peskar BA; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):207-10. PubMed ID: 1589447
[TBL] [Abstract][Full Text] [Related]
23. Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.
Cawello W; Leonhardt A; Schweer H; Seyberth HW; Bonn R; Lomeli AL
Br J Clin Pharmacol; 1995 Sep; 40(3):273-6. PubMed ID: 8527291
[TBL] [Abstract][Full Text] [Related]
24. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
25. [Effect of preoperative administration of prostaglandin E1 on cerebral blood flow in newborns with ductal-dependent congenital cardiac malformations].
Simon M; Cucerea M; Dimitriu AG; Stamatin M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):399-407. PubMed ID: 20700975
[TBL] [Abstract][Full Text] [Related]
26. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine.
Awas JA; Soteriou MC; Drougas JG; Stokes KA; Roberts LJ; Pinson CW
Transplantation; 1996 Jun; 61(11):1624-9. PubMed ID: 8669108
[TBL] [Abstract][Full Text] [Related]
27. Responsiveness of the ductus arteriosus to prostaglandin E1 assessed by combined cross sectional and pulsed Doppler echocardiography.
Hiraishi S; Fujino N; Saito K; Oguchi K; Kadoi N; Agata Y; Horiguchi Y; Hozumi H; Yashiro K
Br Heart J; 1989 Aug; 62(2):140-7. PubMed ID: 2765326
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E1 produces spasmolytic effects on histamine-induced bronchoconstriction in dogs.
Hashimoto Y; Hirota K; Ohtomo N; Sato T; Ishihara H; Matsuki A
Crit Care Med; 1999 Dec; 27(12):2755-9. PubMed ID: 10628622
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin Infusion in Neonate With Severe Coarctation of the Aorta With Closed Ductus Arteriosus-A Case Report and Review of the Literature.
Bansal N; Balakrishnan PL; Aggarwal S
World J Pediatr Congenit Heart Surg; 2020 Jul; 11(4):NP239-NP243. PubMed ID: 31010402
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
Heymann MA; Clyman RI
Pharmacotherapy; 1982; 2(3):148-55. PubMed ID: 6763200
[TBL] [Abstract][Full Text] [Related]
31. A novel approach to ductal spasm during percutaneous device occlusion of patent ductus arteriosus.
De Decker R; Comitis G; Thomas J; van der Merwe E; Lawrenson J
Cardiol Young; 2016 Oct; 26(7):1352-8. PubMed ID: 26692358
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease.
Graham TP; Atwood GF; Boucek RJ
South Med J; 1978 Oct; 71(10):1238-41, 1246. PubMed ID: 81528
[TBL] [Abstract][Full Text] [Related]
33. Intravenous prostaglandin E1 (alprostadil) bolus in ductus arteriosus-dependent CHD: valid or absolutely contraindicated?
Colín Ortiz JL; Cruz Hernández A; Silva Estrada JA; Maldonado Alonso R; Corona Villalobos CA; González Rebeles Guerrero C; Pérez Pérez LF
Cardiol Young; 2024 Feb; 34(2):314-318. PubMed ID: 37403735
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S; Hundalani SG; Kulkarni M; Fernandes CJ; Cabrera AG; Shivanna B; Pammi M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011417. PubMed ID: 29486048
[TBL] [Abstract][Full Text] [Related]
35. Response to prostaglandin E1 in neonates with intracranial arteriovenous malformation treated for suspected congenital heart disease.
Covert RF
Pediatr Cardiol; 1994; 15(2):81-4. PubMed ID: 7997419
[TBL] [Abstract][Full Text] [Related]
36. Utilizing immunoaffinity chromatography (IAC) cross-reactivity in GC-MS/MS exemplified at the measurement of prostaglandin E1 in human plasma using prostaglandin E2-specific IAC columns.
Tsikas D; Suchy MT; Tödter K; Heeren J; Scheja L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():101-107. PubMed ID: 25944643
[TBL] [Abstract][Full Text] [Related]
37. Aneurysmal change of the ductus arteriosus after prostaglandin E1 administration for pulmonary atresia: demonstration with magnetic resonance imaging.
Tsubata S; Hashimoto I; Ichida F; Miyazaki A; Okada T; Murakami A; Morita H; Fukahara K
Pediatr Cardiol; 1994; 15(1):30-2. PubMed ID: 8115269
[TBL] [Abstract][Full Text] [Related]
38. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
Fernández MA; Gebara E
Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
[TBL] [Abstract][Full Text] [Related]
39. Systemic levels following PGE1 inhalation in neonatal hypoxemic respiratory failure.
Sood BG; Glibetic M; Aranda JV; Delaney-Black V; Chen X; Shankaran S
Acta Paediatr; 2006 Sep; 95(9):1093-8. PubMed ID: 16938756
[TBL] [Abstract][Full Text] [Related]
40. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.
Lewis AB; Takahashi M; Lurie PR
J Pediatr; 1978 Sep; 93(3):481-5. PubMed ID: 690772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
